NGR-IL-12 (MolMed)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNGR-IL-12 (MolMed)
Drug Alias Namevascular targeting IL-12 (MolMed)NGR-IL-12
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-12 receptor stimulantsAminopeptidase N modulators
TargetsInterleukin-12 receptorAminopeptidase N
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgc Biologics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgc Biologics
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A